Popular drug that treats diabetes can reduce blood cancer risk
Danish researchers find metformin reduces MPN and solid cancer risks. Metformin aids in lowering colorectal, breast, and prostate cancer risk but may not show clinical benefit in all cases. It also helps with weight loss, PCOS symptoms, cardiovascular health, and neuroprotection.
DNA News Desk
0
8
Danish researchers find metformin reduces MPN and solid cancer risks. Metformin aids in lowering colorectal, breast, and prostate cancer risk but may not show clinical benefit in all cases. It also helps with weight loss, PCOS symptoms, cardiovascular health, and neuroprotection. 
